Abstract:Background: There are abundant glycyrrhetinic acid (GA) receptors on the cellular membrane of hepatocytes and hepatocellular carcinoma (HCC) cells. The receptor binding effect might be related to the structure of the guiding molecule. GA exists in two stereoisomers with C3-hydroxyl and C11-carbonyl active groups. Purpose: The objective of this study was to investigate the relationship between the HCCtargeted effect and the configurations and groups of GA. Methods and results: Different GA derivatives (18 beta-GA, 18 alpha-GA, 3-acetyl-18 beta-GA [3-Ace-GA] and 11-deoxy-18 beta-GA [11-Deo-GA]) were used to investigate the targeting effect of GA's configurations and groups on HCC cells. The EC50 values of competition to binding sites and the ratio of specific binding in HepG2 cells showed that 18 beta-GA and 3-Ace-GA demonstrated significant competitive effect with fluorescein isothiocyanate (FITC)-labeled GA. Then, the GA derivatives were distearoyl-phosphatidylethanolamine (DSPE)-PEGylated. 18 beta-GA-, 18 alpha-GA-, 3-Ace-GA- and 11-Deo-GA-modified liposomes were prepared and characterized by size, zeta potential, encapsulation efficiency, loading capacity, leakage and membrane stability. Evaluation on the cellular location in vitro and tumor targeting in vivo was carried out. Compared to common long-circulation liposome (PEG-Lip), more 18 beta-GA-and 3-Ace-GA-modified liposomes aggregated around HepG2 cells in vitro in short time and transferred into HCC tumors in vivo for a longer time. Conclusion: The beta-configuration hydrogen atom on C18 position of GA played the most important role on the targeting effect. C11-carbonyl and C3-hydroxy groups of GA have certain and little influence on targeting action to HCC, respectively. In general, GA might be a promising targeting molecule for the research on liver diseases and hepatoma therapy.

QUALITATIVE AND QUANTITATIVE EVALUATION OF GLYCYRRHETINIC ACID MODIFIED ALGINATE LIVER TARGETING DRUG DELIVERY SYSTEMS

Preparation of Liver-targeted Nano-prodrug Based on Sodium Alginate Derivative and the Study on Antitumor Activity

Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy.

Cytotoxicity of liver targeted drug-loaded alginate nanoparticles

Doxorubicin-loaded Glycyrrhetinic Acid-Modified Alginate Nanoparticles for Liver Tumor Chemotherapy.

Glycyrrhetinic Acid-Modified Chitosan/poly(ethylene Glycol) Nanoparticles for Liver-Targeted Delivery

Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid.

Insight into Glycyrrhetinic Acid: the Role of the Hydroxyl Group on Liver Targeting.

Ethylene glycol oligomer modified-sodium alginate for efficiently improving the drug loading and the tumor therapeutic effect

Glycyrrhetinic Acid-Modified Poly(ethylene Glycol)-B-poly(gamma-benzyl L-Glutamate) Micelles for Liver Targeting Therapy.

Glycyrrhetinic Acid-Functionalized Degradable Micelles As Liver-Targeted Drug Carrier

Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy

[Preparation and characterization of glycyrrhetinic acid-modified nano graphene oxide drug delivery system]

Development of glycyrrhetinic acid ligand-functionalized liposomes for targeting hepatocellular carcinoma: synthesis, preparation, characterization, and evaluation

Hepatocellular Carcinoma-Targeted Effect of Configurations and Groups of Glycyrrhetinic Acid by Evaluation of Its Derivative-Modified Liposomes

Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.

Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment

Alginic Acid Nanoparticles Prepared Through Counterion Complexation Method As a Drug Delivery System.

Hepatic targeting of glycyrrhetinic acid via nanomicelles based on stearic acid-modified fenugreek gum

Preparation, characterization, and in vivo evaluation of glycyrrhetinic acid-mediated nano-drug delivery system co-loaded with syringopicroside and hydroxytyrosol

Glycyrrhetinic Acid-Poly(ethylene Glycol)-Glycyrrhetinic Acid Tri-Block Conjugates Based Self-Assembled Micelles for Hepatic Targeted Delivery of Poorly Water Soluble Drug